Fig. 4From: A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancerCorrelation between CA125 values from the multiplex PEA used in the discovery step and from clinical ELISA, for benign tumors (in black) and ovarian cancer patients (in red)Back to article page